Formulation Optimization and Stability of Polymyxin B Based on Sodium Deoxycholate Sulfate Micelles

Sunisa Kaewpaiboon1, Teerapol Srichana1

  • 1Drug Delivery System Excellence Center, Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.

Insights

Optimizing the ratio of Polymyxin B (PMB) and sodium deoxycholate sulfate (SDCS) created stable micelles. Lower SDCS ratios stabilized PMB, maintaining antimicrobial activity against Pseudomonas aeruginosa.

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science
  • Biochemistry

Background:

  • Polymyxin B (PMB) is a critical antibiotic, but its stability and delivery require optimization.
  • Sodium deoxycholate sulfate (SDCS) is a bile salt with surfactant properties, potentially useful for drug formulation.

Purpose of the Study:

  • To optimize the mole ratios of PMB and SDCS for stable micelle formation.
  • To characterize the self-assembly, stability, and antimicrobial activity of PMB-SDCS formulations.

Main Methods:

  • Dynamic light scattering (DLS) for micelle size and self-assembly.
  • Fourier-transform infrared spectroscopy (FTIR) and 1H-NMR for chemical characterization.
  • Tandem mass spectrometry for chemical stability assessment.
  • Antimicrobial testing against Pseudomonas aeruginosa.

Main Results:

  • Optimized PMB-SDCS mole ratios yielded micelles with hydrodynamic diameters ranging from 193 to 318 nm.
  • FTIR confirmed hydrogen bonding between PMB and SDCS; NMR showed no significant chemical shift changes.
  • Lower SDCS:PMB ratios (e.g., 5:1) stabilized PMB, enabling release within 30 minutes and maintaining antimicrobial activity (MBC = 2 μg/ml).

Conclusions:

  • The optimized PMB-SDCS micellar system provides physical and chemical stability for Polymyxin B.
  • Specific mole ratios, particularly lower SDCS content, are crucial for effective PMB stabilization and controlled release.
  • This formulation holds promise for enhancing the therapeutic utility of Polymyxin B.

Related Concept Videos

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
416
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
282
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.1K